Computational Simulations in Drug Discovery: Modeling Protein Folding and Drug Binding

Year : 2025 | Volume : 14 | Issue : 01 | Page : 23 29
    By

    Aashish Verma,

  1. Student, Department of Biotechnology, Khwaja Moinuddin Chishti Language University, Lucknow, Uttar Pradesh, India

Abstract

Computational simulations have become essential tools in drug discovery, offering unprecedented insights into molecular behavior at the atomic level. These simulations, particularly in the domains of protein folding and drug binding, allow for the exploration of complex biological systems that are often difficult to study experimentally. Protein folding, a critical aspect of drug discovery, involves the transition of a polypeptide chain from an unfolded to a biologically active structure. Understanding this process is vital for drug design, as the native conformation of a protein determines its functional activity and potential as a therapeutic target. Even with major progress in experimental techniques, predicting how proteins fold is still a difficult task for computers. This is because proteins can take on an enormous number of possible shapes, making it challenging to determine the correct one. Molecular dynamics (MD) simulations have emerged as one of the most powerful tools for exploring protein folding pathways and understanding the dynamic nature of proteins in solutions. Enhanced sampling methods, such as replica exchange molecular dynamics (REMD) and accelerated molecular dynamics (aMD), have helped overcome the timescale limitations of traditional MD simulations, making it possible to capture rare events like protein folding in more detail. Understanding how small molecules bind to and interact with proteins is a critical aspect of drug discovery. This insight is fundamental to developing effective and precise therapies. Computational approaches like molecular docking, molecular dynamics simulations, and free energy calculations allow for the prediction of protein-ligand interactions, offering insights into binding affinities, binding sites, and the mechanisms of action. Docking methods are widely used to predict the binding pose of ligands to their target proteins, while MD simulations provide dynamic information about ligand binding, including conformational changes in the protein. ML algorithms can now predict protein structures and drug binding affinities with greater accuracy, reducing the need for extensive simulations and enabling the design of more efficient drug candidates. While challenges remain – such as accurately modeling solvent effects and the computational cost of large-scale simulations – the future of computational simulations in drug discovery looks promising. With continued advancements in simulation techniques, AI, and hybrid methods that combine various approaches, computational simulations are poised to play an increasingly central role in the identification and optimization of new therapeutics, ultimately accelerating the drug development process and improving patient outcomes.

Keywords: Computational simulations, drug discovery, protein folding, molecular dynamics (MD) simulations, replica exchange molecular dynamics (REMD), accelerated molecular dynamics (AMD)

[This article belongs to Research and Reviews : Journal of Computational Biology ]

How to cite this article:
Aashish Verma. Computational Simulations in Drug Discovery: Modeling Protein Folding and Drug Binding. Research and Reviews : Journal of Computational Biology. 2025; 14(01):23-29.
How to cite this URL:
Aashish Verma. Computational Simulations in Drug Discovery: Modeling Protein Folding and Drug Binding. Research and Reviews : Journal of Computational Biology. 2025; 14(01):23-29. Available from: https://journals.stmjournals.com/rrjocb/article=2025/view=194698


References

1. Al Quraishi M, Sorger PK. Differentiable biology: using deep learning for biophysics-based and data-driven modeling of molecular mechanisms. Nat Methods. 2021;18(10):1169–1180. doi:10.1038/s41592-021-01283-4.
2. Al Quraishi M. End-to-end differentiable learning of protein structure. Cell Syst. 2019;8(4):292–301.e3. doi:10.1016/j.cels.2019.03.006.
3. Baker D, Sali A. Protein structure prediction and structural genomics. Sci. 2001;294(5540):93–96.
4. Hospital A, Goñi JR, Orozco M, Gelpí JL. Molecular dynamics simulations: advances and applications. Adv Appl Bioinform Chem. 2015;8:37–47. doi:10.2147/AABC.S70333.
5. Bronowska AK. Thermodynamics of ligand-protein interactions: implications for molecular design. InThermodynamics-Interaction Studies-Solids, Liquids and Gases 2011. doi:10.5772/19447.
6. Durrant JD, McCammon JA. Molecular dynamics simulations and drug discovery. BMC Biol. 2011;9:71. doi:10.1186/1741-7007-9–71.
7. Dill KA, MacCallum JL. The protein-folding problem, 50 years on. science. 2012;338(6110):1042–1046.
8. Zhou Y, Chen J, Cheng J, Karemore G, Zitnik M, Chong FT, Liu J, Fu T, Liang Z. Quantum-machine-assisted drug discovery: Survey and perspective. arXiv preprint arXiv:2408.13479. 2024.
9. Gohlke H, Case DA. Converging free energy estimates: MM‐PB (GB) SA studies on the protein–protein complex Ras–Raf. J Comput Chem. 2004;25(2):238–250.
10. Das P. Computational Investigations on p53-MDM2 Interaction and its Inhibition: A Significant Step in Cancer Therapy [Doctoral dissertation]. Tezpur: Tezpur University; 2023.
11. Yuriev E, Agostino M, Ramsland PA. Challenges and advances in computational docking: 2009 in review. J Mol Recognit. 2011;24(2):149–164. doi:10.1002/jmr.1077.
12. Jorgensen WL. The many roles of computation in drug discovery. Sci. 2004;303(5665):1813–1818. doi:10.1126/science.1096361.
13. Mark P, Nilsson L. Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. J Phys Chem A. 2001;105(43):9954–9960.
14. Karplus M, McCammon JA. Molecular dynamics simulations of biomolecules. Nat Struct Biol. 2002;9(9):646–652.
15. Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov. 2004;3(11):935–949.
16. Schlick T, Collepardo-Guevara R, Halvorsen LA, Jung S, Xiao X. Biomolecular modeling and simulation: a field coming of age. Quarterly Rev Biophys. 2011;44(2):191–228.
17. Prigogine I, Rice SA. Proteins: A Theoretical Perspective of Dynamics, Structure, and Thermodynamics. USA: John Wiley & Sons; 2009.
18. Fuller JC, Burgoyne NJ, Jackson RM. Predicting druggable binding sites at the protein-protein interface. Drug Discov Today. 2009;14(3-4):155–161. doi:10.1016/j.drudis.2008.10.009.
19. Chaudhary M, Tyagi K. A review on molecular docking and its application. Int J Adv Res. 2024;12(03):1141–1153. doi:10.21474/ijar01/18505.
20. ‌Rossi MA, et al. Virtual screening in drug discovery. J Med Chem. 2013;56(15):6375–6386.
21. Senior AW, Evans R, Jumper J, Kirkpatrick J, Sifre L, Green T, Qin C, Žídek A, Nelson AWR, Bridgland A, Penedones H, Petersen S, Simonyan K, Crossan S, Kohli P, Jones DT, Silver D, Kavukcuoglu K, Hassabis D. Improved protein structure prediction using potentials from deep learning. Nature. 2020;577(7792):706–710. doi:10.1038/s41586-019-1923–7.
22. Shakhnovich E. Protein folding thermodynamics and dynamics: where physics, chemistry, and biology meet. Chem Rev. 2006;106(5):1559–1588. doi:10.1021/cr040425u.
23. Dara S, Dhamercherla S, Jadav SS, Babu CM, Ahsan MJ. Machine learning in drug discovery: A review. Artif Intell Rev. 2022;55(3):1947–1999. doi:10.1007/s10462-021-10058-4.

Regular Issue Subscription Review Article
Volume 14
Issue 01
Received 23/12/2024
Accepted 13/01/2025
Published 20/01/2025
Publication Time 28 Days
291

Login


My IP

PlumX Metrics